New Alliance Aims to Accelerate Adoption - Takeaways - MDSpire

New Alliance Aims to Accelerate Adoption

  • June 9, 2026

Share

  • 1

    IQity has partnered with Sightpath Medical to accelerate the adoption of new ophthalmic diagnostic and surgical technologies in the U.S.

  • 2

    The partnership combines IQity's technology portfolio with Sightpath's logistics and support infrastructure for enhanced operational efficiency.

  • 3

    Sightpath will support the launch of IQity's products, including a digital robotic surgical microscope and a handheld glaucoma treatment device.

  • 4

    The collaboration aims to address challenges in ophthalmology by improving clinical outcomes while reducing costs and workflow burdens.

  • 5

    The partnership signifies Sightpath's expansion beyond equipment access, leveraging its expertise to support IQity's product introductions.

Original Source(s)

New Alliance Aims to Accelerate Adoption

  • June 9, 2026

Related Content

VR Perimetry May Match HVF in Glaucoma

Virtual reality testing shortened visual field exams and was preferred among most patients in a retrospective study.

OCT Shows Slowing of Structural Glaucoma Progression After SLT 

“Results suggest that SLT may help slow progression of glaucomatous damage over time,” said Raeesah Ahsan, BA, in her presentation.  

Case Report: Novel FOXC1 variant c.311T>G (p.Ile104Ser) in a Chinese family with Axenfeld-Rieger syndrome